On the other hand, it could also play as an oncogene, and its overexpression is correlated with the poor outcome of NSCLC patients in clinical treatment, and promotes the migration and proliferation of NSCLC cells by downregulating TGFβR1 (57). The gene discussed is TGFBR1; the disease is non-small cell lung carcinoma.